Associated Papers
Analysis of BRCA1 germline variants (exons 5, 11 and 20) in breast cancer families from Libya.
Elmaihub ES et al.
The Libyan Journal of Medicine, 2024
HRD Testing of Ovarian Cancer in Routine Practice: What Are We Dealing With?
Kekeeva T et al.
International Journal of Molecular Sciences, 2023
37445679 (PubMed )
Supplement: ijms-24-10497-s001.zip › ijms-2442047-supplementary.xlsx › ____1
Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer.
Gorodnova TV et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 2018
Select a paper to view details